Spatiotemporal control of reactive oxygen species in T cells
T 细胞中活性氧的时空控制
基本信息
- 批准号:9107630
- 负责人:
- 金额:$ 37.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigen PresentationAntigen-Presenting CellsAntigensBehaviorBindingBiologicalBiological ModelsCalciumCell membraneCell modelCellsCharacteristicsClassificationClinical TrialsCollaborationsCommunicationDetectionDevelopmentDiagnosisDifferential EquationDiseaseDyesEventFrequenciesFundingGenerationsHealthHeterogeneityHydrogen PeroxideImmuneImmunologyIndividualInvestigationKnowledgeLifeLigationLocationMeasurementMembraneMetabolicMethodologyMethodsMicrofluidicsMicrotubulesMitochondriaModelingMonitorMovementOrganellesOutcomeOxidantsOxidasesOxidation-ReductionOxidative RegulationOxidative StressPeptide/MHC ComplexPeptidesPhagocytesPhenotypePlayPopulationPopulation DistributionsProcessProductionProtein DynamicsProteinsRNAReactive Oxygen SpeciesRegulationResearchRoleSignal TransductionSiteSourceStimulusSystemT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTechnologyTestingTimeVariantWorkanalytical toolbasecellular imagingdata acquisitiondensitydesignextracellularhigh throughput analysisimaging modalityimmunological synapseimmunological synapse formationimprovedinnovationinsightmigrationnanometernoveloxidationprotein expressionreceptorresponsesensorsingle cell analysisspatiotemporal
项目摘要
DESCRIPTION (provided by applicant): Reactive oxygen species (ROS) are produced in distinct cellular locations - by the organelle location of oxidases and mitochondria - and exert their effects only nanometers from the site of production. Little is known about how cells regulate production of reactive oxygen species to control signal transduction. The objective of this application is a detailed quantitative analysis of the local intercellular regulation of ROS ad its control over immunological processes. Observations of mitochondrial migration during T cell activation have been largely attributed to local ATP demands; however our findings of active redox signal regulation and quantitative modeling of intracellular H2O2 leads us to hypothesize that T cells coordinate mitochondrial movement to the immunological synapse (IS) to control T cell activation signaling via ROS production. The long-term rationale for this research is that by understanding how ROS is used to oxidize proteins during signaling, methods of targeting mitochondrial function can be appropriately applied to augment or suppress self- or antigenic peptide presentation. This project will yield new experimental platforms and analytical tools for cellular interaction studies in conjunction with quantitative insight of T cell responsiveness as a
function of metabolic phenotype. First, we will develop a high-throughput acquisition platform for monitoring T cell/antigen-presenting cell engagement. Secondly, single cell frequency response signatures from oxidative stimuli will be related to T cell activation and IS features. Finally, we
will model regional oxidation during TCR ligation to test the hypothesis that the mitochondrial movement that occurs during IS formation creates oxidized zones proximal to the pMHC:TCR interface. These technologies will be used to determine the contributions of localized ROS sources to T cell signaling and investigate spatiotemporal relationships between ROS generation and calcium. The proposed research is innovative because it merges the technological developments of new modeling methods and microfluidic platforms to address the challenge of analyzing local oxidation during T cell signaling. The outcomes of this work are expected to fundamentally advance our understanding of how cells use spatially distinct ROS sources to regulate receptor-initiated signaling. This knowledge will have large impact in ultimately redefining intracellular oxidation by more biologically relevant metrics for diagnosis and treatment of diseases.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa Lambeth Kemp其他文献
Mediation of Doxorubicin Toxicity in Cancer Cells by Coupled Redox Reactions
- DOI:
10.1016/j.freeradbiomed.2010.10.119 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Nnenna Jacinta Adimora;John Charles Vaughns;Melissa Lambeth Kemp - 通讯作者:
Melissa Lambeth Kemp
Tgfβ-Mediated Epithelial-Mesenchymal Transition is a Function of Cellular Redox Reprogramming
- DOI:
10.1016/j.freeradbiomed.2011.10.035 - 发表时间:
2011-11-01 - 期刊:
- 影响因子:
- 作者:
Adam Franklin Prasanphanich;Melissa Lambeth Kemp - 通讯作者:
Melissa Lambeth Kemp
Reciprocal Positive Feedback Between ROS and TGFβ During Epithelial-Mesenchymal Transition in Lung Carcinoma Cells
- DOI:
10.1016/j.freeradbiomed.2012.10.129 - 发表时间:
2012-11-01 - 期刊:
- 影响因子:
- 作者:
Adam Franklin Prasanphanich;Michael Butler;Melissa Lambeth Kemp - 通讯作者:
Melissa Lambeth Kemp
Melissa Lambeth Kemp的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa Lambeth Kemp', 18)}}的其他基金
Spatiotemporal control of reactive oxygen species in T cells
T 细胞中活性氧的时空控制
- 批准号:
8316150 - 财政年份:2011
- 资助金额:
$ 37.14万 - 项目类别:
Spatiotemporal control of reactive oxygen species in T cells
T 细胞中活性氧的时空控制
- 批准号:
8040568 - 财政年份:2011
- 资助金额:
$ 37.14万 - 项目类别:
Spatiotemporal control of reactive oxygen species in T cells
T 细胞中活性氧的时空控制
- 批准号:
8704863 - 财政年份:2011
- 资助金额:
$ 37.14万 - 项目类别:
Spatiotemporal control of reactive oxygen species in T cells
T 细胞中活性氧的时空控制
- 批准号:
8512651 - 财政年份:2011
- 资助金额:
$ 37.14万 - 项目类别:
Redox regulation of cellular information processing
细胞信息处理的氧化还原调节
- 批准号:
7848626 - 财政年份:2009
- 资助金额:
$ 37.14万 - 项目类别:
MICROFLUIDIC SYSTEM FOR HIGH-THROUGHPUT EVALUATION OF T CELL FUNCTIONALITY WITH H
使用 H 对 T 细胞功能进行高通量评估的微流控系统
- 批准号:
7677480 - 财政年份:2008
- 资助金额:
$ 37.14万 - 项目类别:
MICROFLUIDIC SYSTEM FOR HIGH-THROUGHPUT EVALUATION OF T CELL FUNCTIONALITY WITH H
利用 H 对 T 细胞功能进行高通量评估的微流控系统
- 批准号:
7501611 - 财政年份:2008
- 资助金额:
$ 37.14万 - 项目类别:
相似海外基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
- 批准号:
10734324 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
- 批准号:
23K04971 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
- 批准号:
2885451 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10385926 - 财政年份:2022
- 资助金额:
$ 37.14万 - 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
- 批准号:
10509043 - 财政年份:2022
- 资助金额:
$ 37.14万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10704008 - 财政年份:2022
- 资助金额:
$ 37.14万 - 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
- 批准号:
10818273 - 财政年份:2022
- 资助金额:
$ 37.14万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10349397 - 财政年份:2022
- 资助金额:
$ 37.14万 - 项目类别: